Accuracy of Glomerular Filtration Rate Estimates among Patients with Cancer

Background: Little is known about the accuracy of glomerular filtration rate (GFR) assessment among people with cancer. Most cancer guidelines and trials recommend estimated creatinine clearance (eClcr) using the Cockcroft-Gault (CG) equation. Accuracy is key to determine cancer prognosis, treatment eligibility and correct dosing of treatments with narrow therapeutic index. Methods: We performed a cross-sectional study including 1,781 adults with incident cancer referred for 1,989 determinations of measured GFR (mGFR) using single-point plasma clearance of iohexol in Stockholm, Sweden, with concurrent measurements of creatinine and cystatin C. We assessed the performance of eClcr, estimated GFR based on creatinine (eGFRcr: CKD-EPI 2009/2021, EKFC 2021), cystatin C (eGFRcys: CKD-EPI 2012, EKFC 2023) and the combination (eGFRcr-cys: CKD-EPI 2012/2021, EKFC 2023) equations against mGFR. Values were non-indexed to body surface area and reported in mL/min. Accuracy was reported as % of patients with estimated values that differed by more than 30% of mGFR (1-P30). Bias was estimated as median (interquartile range; IQR) difference between mGFR and eCrcl or eGFR. Results: Mean age was 64 (SD 14) years, 36% were female with mean mGFR 76 (SD 31) mL/min. The most common cancers were bladder (41%), lung (15%) and colorectal (13%); 13% had metastatic disease. 1-P30 was best for eGFRcr-cys (6-8%). eClcr (1-P30: 17%) had similar accuracy to eGFRcr (1-P30: 13-26%) and eGFRcys (1-P30: 12-17%). Accuracy varied by mGFR (Figure A). Median bias was lowest for eGFRcr-cys CKD-EPI 2012 (-0.5, IQR -6.2 to 6.4 mL/min) and highest for eGFRcr CKD-EPI 2021 (9.8, IQR 0.9 to 19.7 mL/min). Across mGFR categories, eGFRcr-cys equations were the least biased (Figure B). Conclusion: Non-indexed eGFRcr-cys with CKD-EPI and EKFC equations provide the most accurate estimates of mGFR in patients with cancer, with potential to improve dosing and classification across treatment thresholds compared to eClcr and eGFRcr.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024w8sh7fhq
Primary Topic
Multiple and Secondary Primary Cancers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Accuracy of Glomerular Filtration Rate Estimates among Patients with Cancer

Anne‐Laure Faucon, Edouard L. Fu, Andrew S. Levey, Patrick Barry Mark et al.
Journal of the American Society of Nephrology
Multiple and Secondary Primary Cancers
article

Accuracy of Glomerular Filtration Rate Estimates among Patients with Cancer

Anne‐Laure Faucon, Edouard L. Fu, Andrew S. Levey, Patrick Barry Mark, Juan Jesús Carrero, Lesley A. Inker, Jennifer Susan Lees, Benjamin Elyan
article en

Abstract

Background: Little is known about the accuracy of glomerular filtration rate (GFR) assessment among people with cancer. Most cancer guidelines and trials recommend estimated creatinine clearance (eClcr) using the Cockcroft-Gault (CG) equation. Accuracy is key to determine cancer prognosis, treatment eligibility and correct dosing of treatments with narrow therapeutic index. Methods: We performed a cross-sectional study including 1,781 adults with incident cancer referred for 1,989 determinations of measured GFR (mGFR) using single-point plasma clearance of iohexol in Stockholm, Sweden, with concurrent measurements of creatinine and cystatin C. We assessed the performance of eClcr, estimated GFR based on creatinine (eGFRcr: CKD-EPI 2009/2021, EKFC 2021), cystatin C (eGFRcys: CKD-EPI 2012, EKFC 2023) and the combination (eGFRcr-cys: CKD-EPI 2012/2021, EKFC 2023) equations against mGFR. Values were non-indexed to body surface area and reported in mL/min. Accuracy was reported as % of patients with estimated values that differed by more than 30% of mGFR (1-P30). Bias was estimated as median (interquartile range; IQR) difference between mGFR and eCrcl or eGFR. Results: Mean age was 64 (SD 14) years, 36% were female with mean mGFR 76 (SD 31) mL/min. The most common cancers were bladder (41%), lung (15%) and colorectal (13%); 13% had metastatic disease. 1-P30 was best for eGFRcr-cys (6-8%). eClcr (1-P30: 17%) had similar accuracy to eGFRcr (1-P30: 13-26%) and eGFRcys (1-P30: 12-17%). Accuracy varied by mGFR (Figure A). Median bias was lowest for eGFRcr-cys CKD-EPI 2012 (-0.5, IQR -6.2 to 6.4 mL/min) and highest for eGFRcr CKD-EPI 2021 (9.8, IQR 0.9 to 19.7 mL/min). Across mGFR categories, eGFRcr-cys equations were the least biased (Figure B). Conclusion: Non-indexed eGFRcr-cys with CKD-EPI and EKFC equations provide the most accurate estimates of mGFR in patients with cancer, with potential to improve dosing and classification across treatment thresholds compared to eClcr and eGFRcr.

Journal of the American Society of NephrologyVol. 35(10S)
Tufts University (US), Leiden University Medical Center (NL), Karolinska Institutet (SE), University of Glasgow (GB)
Zero hunger
Openalex Percentile: Top 71%
Multiple and Secondary Primary Cancers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.